19 October 2016 - Addressing high drug prices has become a key priority for American health policy. Both presidential candidates have discussed it, and congressional hearings on the subject have become fairly normal. 

The question, then, isn’t whether we’ll do something on drug pricing, but what that something will be.

On this front, the Center for American Progress deserves some credit. Their recent drug price reform proposal takes a big step beyond the usual talking points about drug prices. 

The authors of the proposal envision a system of “binding arbitration” to mediate high drug prices. The basic idea is to find an alternative to national drug formularies (how most countries control drug prices) while still pushing down drug prices.

Read Forbes article